Your healthcare provider will closely monitor your progress, adjust dosages as needed, and address any potential side effects
Manufactured by Novo Nordisk, this revolutionary drug led the way for new obesity treatment options after researchers discovered that substantial weight loss was an unexpected but potentially positive side effect in early clinical trials
Genetic Predispositions in GLP-1 and GIPR Pathways and Transition Planning Your genetic architecture in GLP1R rs6923761 and GIPR rs1800437 variants may influence how efficiently your cells respond to semaglutide alone versus tirzepatide's dual activation
As subcutaneous fat decreases, cold sensitivity often increases
Underdosing may reduce the effectiveness of your treatment, while overdosing could increase the risk of side effects like nausea, vomiting, dizziness, or low blood sugar